FCCC LOGO Faculty Publications
Koshy MC , Landry JC , Cavanaugh SX , Fuller CD , Willett CG , Abrams RA , Hoffman JP , Thomas Jr CR
A challenge to the therapeutic nihilism of ESPAC-1
International Journal of Radiation Oncology Biology Physics. 2005 ;61(4) :965-966
Back to previous list
03603016 (ISSN) Cited By: 3; Export Date: 25 May 2006; Source: Scopus CODEN: IOBPD; DOI: 10.1016/j.ijrobp.2004.11.018 Language of Original Document: English Correspondence Address: Thomas Jr., C.R.; Radiation Oncology; Univ. Texas Sci. Ctr. at S. Antonio; 7979 Wurzbach Rd. San Antonio, TX 78229, United States; email: cthomas@ctrc.net Chemicals/CAS: Antimetabolites, Antineoplastic; Fluorouracil, 51-21-8 References: Neoptolemos, J.P., Stocken, D.D., Friess, H., A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer (2004) N Engl J Med, 350, pp. 1200-1210; Choti, M.A., Adjuvant therapy for pancreatic cancer--the debate continues (2004) N Engl J Med, 350, pp. 1249-1251; Moertel, C.G., Frytak, S., Hahn, R.G., Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group (1981) Cancer, 48, pp. 1705-1710; Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone (1988) J Natl Cancer Inst, 80, pp. 751-755, Gastrointestinal Tumor Study Group; Kalser, M.H., Ellenberg, S.S., Pancreatic cancer: Adjuvant combined radiation and chemotherapy following curative resection (1985) Arch Surg, 120, pp. 899-903; Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer (1987) Cancer, 59, pp. 2006-2010, Gastrointestinal Tumor Study Group; Yeo, C.J., Abrams, R.A., Grochow, L.B., Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: A prospective, single-institution experience (1997) Ann Surg, 225, pp. 621-633; Klinkenbijl, J.H., Jeekel, J., Sahmoud, T., Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group (1999) Ann Surg, 230, pp. 776-782; Qian, W., Parmar, M.K.B., Sambrook, R.J., Fayers, P.M., Girling, D.J., Stephens, R.J., Analysis of messy longitudinal data from a randomized clinical trial (2000) Stat Med, 19, pp. 2657-2674; Werner-Wasik, M., Pequignot, E., Leeper, D., Hauck, W., Curran, W., Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: A multivariate analysis of patients with lung cancer treated with nonoperative therapy (2000) Int J Radiat Oncol Biol Phys, 48, pp. 689-696.